Respiratory Infections

The FDA has issued a safety alert on the potential risk of transmitting SARS-CoV-2, the virus that causes coronavirus diseases 2019 (COVID-19), through fecal microbiota transplantation.

Stay up to date with the latest COVID-19 news from Contagion.

Investigations in the US and China make a case for using convalescent plasma, a “last resort” for SARS, as an early treatment for COVID-19.

A new serological assay was developed by a microbiology lab at the Icahn School of Medicine at Mount Sinai.

Tina Q. Tan, MD, discusses the particular severity of the ongoing flu season.

From PPE shortages to scared staff, what are hospitals currently facing and how can they respond?

The analysis included countries around the world, but the investigators also classified the data by WHO region.

Stay up to date with the latest COVID-19 news from Contagion.

Jason Pogue, PharmD, BCPS, BCIDP, shares his thoughts on a study published in the International Journal of Antimicrobial Agents.

Contagion is partnering with PER to host a live CME-Certified webinar on what clinicians need to know about COVID-19.

The impact of COVID-19 on cardiovascular health is an urgent question for clinicians around the world during this global pandemic.

A Central Science report from the CAS division of the American Chemical Society details developments and recommends directions against COVID-19 pandemic.

Countries around the world have struggled to keep the spread of COVID-19 in check. In countries with relatively few resources and weak public health infrastructure, the challenge is even more acute.

A quick and effective response by health officials in Uganda stopped a case of imported pneumonic plague from spreading, according to a recent Morbidity and Mortality Weekly Report.

What does it look like when a health system switches from 'containment' to 'mitigation'?

Older people in low-income countries are especially at risk for COVID-19.

The European Union is rethinking its approach to border crossings as the region deals with the COVID-19 pandemic.

Saskia v. Popescu, PhD, MPH, MA, CIC, a senior infection prevention epidemiologist in Phoenix, Arizona, discusses what it’s like for these frontline fighters and what we can do to “flatten the curve.”

Lopinavir-ritonavir worked against SARS, but it had little effect against coronavirus compared to standard care.

Stay on top of coronavirus developments from March 20, 2020.

New analyses of the novel coronavirus and previously circulating SARS viruses reveal promising immunologic targets for vaccine against COVID-19.

Several states are escalating their COVID-19 response measures.

Events that host at-risk people should consider canceling, postponing, or limiting in-person attendance.

A new paper describes how one Singaporean hospital responded to the 2003 severe acute respiratory syndrome (SARS) outbreak, and how those lessons can inform the response to the current pandemic.

The agency notes that they are working closely with industry officials to expedite efforts to develop countermeasures for COVID-19.

Stay on top of coronavirus developments from March 19, 2020.

The FLU-v experimental vaccine designed to protect across influenza strains showed promising results in a recent clinical trial.

A drug known to inhibit a cellular protease TMPRSS2 could potentially be a novel therapeutic intervention for COVID-19 infections, according to German investigators who found that the cellular protein may allow entry of SARS-CoV-2 into lung cells.

The NIH has shared new information on the stability of SARS-CoV-2 virus on a variety of surfaces.

According to Abbott, the systems can run high volumes of up to 470 tests in 24 hours.